Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.8, n°9-10 - September-October 2016
Paru le :
01/10/2016
Année :
2016
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
ANALYSE CHIMIQUE
;
TOXICOLOGIE
;
DROGUES DE SYNTHESE
;
CATHINONES
;
PHARMACOLOGIE
;
DOPAGE
Note de contenu :
SELECTION :
- Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Brandt S.D., Kavanagh P.V., Westphal F., Stratford A., Elliott S.P., Hoang K., et al., p. 891-902.
- Cathinones: Isotopic profiling as an aid to linking seizures. Collins M., Doddridge A., Salouros H., p. 903-909.
- Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs. Westphal F., Girreser U., Waldmüller D., p. 910-919.
- The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer. McLaughlin G., Morris N., Kavanagh P.V., Power J.D., Twamley B., O'Brien J., et al., p. 920-929.
- In vitro evaluation of the effects of anti-fungals, benzodiazepines and non-steroidal anti-inflammatory drugs on the glucuronidation of 19-norandrosterone: implications on doping control analysis. Palermo A., Alessi B., Botrè F., de la Torre X., Fiacco I., Mazzarino M., p. 930-939.
- European guidelines for workplace drug and alcohol testing in hair. Salomone A., Tsanaclis L., Agius R., Kintz P., Baumgartner M.R., p. 996-1004.
- Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn, and LC-HR-MSn. Wink C.S.D., Michely J.A., Jacobsen-Bauer A., Zapp J., Maurer H.H., p. 1005-1014.
- Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone. Carlsson A., Lindberg S., Wu X., Dunne S., Josefsson M., Åstot C., et al., p. 1015-1029.
- Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project. Hermanns-Clausen M., Kithinji J., Spehl M., Angerer V., Franz F., Eyer F., et al., p. 1030-1038.
- Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS. Mardal M., Gracia-Lor E., Leibnitz S., Castiglioni S., Meyer M.R., p. 1039-1048.
- Detection of erythropoietin misuse by the Athlete Biological Passport combined with reticulocyte percentage. Bejder J., Aachmann-Andersen N.J., Bonne T.C., Olsen N.V., Nordsborg N.B., p. 1049-1055.
- Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers. Franke A.A., Li X., Lai J.F., p. 1095-1099.
- Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Brandt S.D., Kavanagh P.V., Westphal F., Stratford A., Elliott S.P., Hoang K., et al., p. 891-902.
- Cathinones: Isotopic profiling as an aid to linking seizures. Collins M., Doddridge A., Salouros H., p. 903-909.
- Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs. Westphal F., Girreser U., Waldmüller D., p. 910-919.
- The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer. McLaughlin G., Morris N., Kavanagh P.V., Power J.D., Twamley B., O'Brien J., et al., p. 920-929.
- In vitro evaluation of the effects of anti-fungals, benzodiazepines and non-steroidal anti-inflammatory drugs on the glucuronidation of 19-norandrosterone: implications on doping control analysis. Palermo A., Alessi B., Botrè F., de la Torre X., Fiacco I., Mazzarino M., p. 930-939.
- European guidelines for workplace drug and alcohol testing in hair. Salomone A., Tsanaclis L., Agius R., Kintz P., Baumgartner M.R., p. 996-1004.
- Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn, and LC-HR-MSn. Wink C.S.D., Michely J.A., Jacobsen-Bauer A., Zapp J., Maurer H.H., p. 1005-1014.
- Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone. Carlsson A., Lindberg S., Wu X., Dunne S., Josefsson M., Åstot C., et al., p. 1015-1029.
- Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project. Hermanns-Clausen M., Kithinji J., Spehl M., Angerer V., Franz F., Eyer F., et al., p. 1030-1038.
- Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS. Mardal M., Gracia-Lor E., Leibnitz S., Castiglioni S., Meyer M.R., p. 1039-1048.
- Detection of erythropoietin misuse by the Athlete Biological Passport combined with reticulocyte percentage. Bejder J., Aachmann-Andersen N.J., Bonne T.C., Olsen N.V., Nordsborg N.B., p. 1049-1055.
- Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers. Franke A.A., Li X., Lai J.F., p. 1095-1099.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
A. SALOMONE ;
L. TSANACLIS ;
R. AGIUS ;
P. KINTZ ;
M. R. BAUMGARTNER
|
2016
Dans Drug Testing and Analysis (Vol.8, n°9-10, September-October 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°9-10, September-October 2016) Article : Périodique
Guidelines for Legally Defensible Workplace Drug Testing have been prepared and updated by the European Workplace Drug Testing Society (EWDTS). They are based on the 2010 version published by Pascal Kintz and Ronald Agius (Guidelines for Europea[...]